SKI Market

Indian Indices

Sensex

78,918.90 -1,097.00
( -1.37%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

55,600.46 322.40
(0.58%)

Nikkei 225

10,286.75 -127.19
(-1.22%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

369.1611632

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

33.37

71531.53

EPS(TTM)

Face Value()

Div & Yield %

36.91

Back

UltraTech Cement consolidated net profit rises 26.92% in the December 2025 quarter

Jan 24,2026

Net profit of UltraTech Cement rose 26.92% to Rs 1725.40 crore in the quarter ended December 2025 as against Rs 1359.43 crore during the previous quarter ended December 2024. Sales rose 22.78% to Rs 21829.68 crore in the quarter ended December 2025 as against Rs 17778.83 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	21829.68	17778.83	23
OPM %	17.91	16.27	-
PBDT	3554.15	2684.05	32
PBT	2372.25	1691.27	40
NP	1725.40	1359.43	27

78,918.90 -1,097.00 ( -1.37%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

55,600.46 322.40 (0.58%)

10,286.75 -127.19 (-1.22%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)